Nov 24 (Reuters) - Eli Lilly (NYSE:LLY) Canada:
* LILLY AND GOVERNMENT OF CANADA SIGN AN AGREEMENT FOR SUPPLY OF BAMLANIVIMAB TO TREAT COVID-19 IN CANADA
* WILL SUPPLY CANADA WITH INITIAL QUANTITY OF 26,000 DOSES OF BAMLANIVIMAB OVER THREE-MONTH BETWEEN DEC. 2020 & FEBRUARY 2021
* WILL SUPPLY CANADA WITH AN INITIAL QUANTITY OF 26,000 DOSES OF BAMLANIVIMAB FOR US$32.5 MILLION
* ADDITIONAL DOSES WILL BE SUPPLIED TO CANADA ON A MONTHLY BASIS ACCORDING TO MEDICAL NEED IN CANADA AND AVAILABILITY OF SUPPLY